Anti-Complement Factor D Antibody Biotin Conjugate (18/1b)
Our mouse Complement Factor D monoclonal biotinylated antibody from Antibodies Incorporated is produced in-house from clone 18/1b. It detects human Complement Factor D and is Protein A or Protein G purified. Works in ELISA.
SKU: GAU 008-01B-015
Ships: 1-2 business days
Product Details
Complement Factor D
Complement factor D is a serine protease of the alternative pathway of complement activation. The protein is a single chain polypeptide with a molecular mass of 25 kDa. Factor D cleaves factor B bound to C3b, generating the alternative pathway C3 convertase C3bBb and releasing the Ba fragment.
Protein A or Protein G purified
1 mg/mL ±15%
Monoclonal
18/1b
IgG1/k
ELISA
Mouse
CFD
Human factor D
Human
Human
2-8°C without exposure to light
Liquid
BSA free
0.01 M phosphate buffer, pH 7.4, with 0.14 M NaCl and 15 mM sodium azide
GAU 008-01 is used as a biotinylated detection antibody in sandwich ELISA with a GAU 010-04 capture. (1)
Biotin
GAU 008-01 is specific for complement factor D in human serum and plasma. Epitope specificity differs from that of GAU 010-04. (1)
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
United States
12 months from date of receipt
DF; CFD; adipsin; PFD; Complement factor D; EC:3.4.21.46; C3 convertase activator; Properdin factor D; complement factor D preproprotein; ADN; D component of complement
Serine protease that initiates the alternative pathway of the complement system, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:21205667, PubMed:22362762, PubMed:6769474, PubMed:874324, PubMed:9748277). In contrast to other complement pathways (classical, lectin and GZMK) that are directly activated by pathogens or antigen-antibody complexes, the alternative complement pathway is initiated by the spontaneous hydrolysis of complement C3 (PubMed:21205667, PubMed:22362762, PubMed:6769474, PubMed:874324). The alternative complement pathway acts as an amplification loop that enhances complement activation by mediating the formation of C3 and C5 convertases (PubMed:21205667, PubMed:22362762, PubMed:6769474, PubMed:874324). Activated CFD cleaves factor B (CFB) when the latter is complexed with complement C3b, activating the C3 convertase of the alternative pathway (PubMed:21205667, PubMed:6769474, PubMed:874324, PubMed:9748277). {ECO:0000269|PubMed:21205667, ECO:0000269|PubMed:22362762, ECO:0000269|PubMed:6769474, ECO:0000269|PubMed:874324, ECO:0000269|PubMed:9748277}.
1675
Shipped on ice packs

